ॲस्टन फार्मास्युटिकल्स IPO
ॲस्टन फार्मास्युटिकल्स IPO तपशील
-
उघडण्याची तारीख
09 जुलै 2025
-
बंद तारीख
11 जुलै 2025
- IPO प्राईस रेंज
₹115 ते ₹123
- IPO साईझ
₹ 26.17 कोटी
ॲस्टन फार्मास्युटिकल्स IPO टाइमलाईन
ॲस्टन फार्मास्युटिकल्स IPO सबस्क्रिप्शन स्थिती
| तारीख | क्यूआयबी | एनआयआय | वैयक्तिक गुंतवणूकदार | एकूण |
|---|---|---|---|---|
| 09-Jul-25 | 3.51 | 0.66 | 1.22 | 1.75 |
| 10-Jul-25 | 4.47 | 19.67 | 16.66 | 13.84 |
| 11-Jul-25 | 85.76 | 353.14 | 172.06 | 186.55 |
अंतिम अपडेट: 27 एप्रिल 2026 5:47 PM पर्यंत 5paisa
ॲस्टन फार्मास्युटिकल्स लिमिटेडचा ₹26.17 कोटीचा IPO सुरू आहे. The company exports a wide range of pharmaceutical products—tablets, capsules, syrups, and more—across key therapeutic areas like antibiotics, vitamins, and analgesics. It operates through direct sales and contract manufacturing on a principle-to-principle basis. With certifications from Central and State FDA and NQA accreditation, Asston adheres to strict Quality Management System (QMS) standards, ensuring consistent product quality.
येथे स्थापित: 2019
मॅनेजिंग डायरेक्टर: Dr. Ashish Narayan Sakalkar
पीअर्स
Shelter Pharma Limited
Bafna Pharmaceuticals Limited
ट्रायडेंट लाईफलाईन लिमिटेड
Asston Pharmaceuticals Objectives
To fund machinery purchases for capital expenditure in the manufacturing unit.
To meet the company's increased working capital requirements.
To repay or prepay the company’s existing borrowings.
सामान्य कॉर्पोरेट उद्देश.
Asston Pharmaceuticals IPO Size
| प्रकार | साईझ |
|---|---|
| एकूण IPO साईझ | ₹ 26.17 कोटी |
| विक्रीसाठी ऑफर | - |
| नवीन समस्या | ₹ 26.17 कोटी |
Asston Pharmaceuticals IPO Lot Size
| ॲप्लिकेशन | लॉट्स | शेअर्स | रक्कम |
|---|---|---|---|
| रिटेल (किमान) | 2 | 2,000 | ₹2,30,000 |
| रिटेल (कमाल) | 2 | 2,000 | ₹2,30,000 |
| एस-एचएनआय (किमान) | 3 | 3,000 | ₹3,45,000 |
| S-HNI (कमाल) | 8 | 8,000 | ₹9,20,000 |
| बी-एचएनआय (किमान) | 9 | 9,000 | ₹10,35,000 |
Asston Pharmaceuticals IPO Reservation
| इन्व्हेस्टर्स कॅटेगरी | सबस्क्रिप्शन (वेळा) | ऑफर केलेले शेअर्स | यासाठी शेअर्स बिड | एकूण रक्कम (कोटी)* |
|---|---|---|---|---|
| क्यूआयबी | 85.76 | 4,25,000 | 3,64,49,000 | 448.32 |
| एनआयआय (एचएनआय) | 353.14 | 3,22,000 | 11,37,10,000 | 1,398.63 |
| वैयक्तिक गुंतवणूकदार (2 लॉट्ससाठी इंड कॅटेगरी बिडिंग) | 172.06 | 7,46,000 | 12,83,58,000 | 1,578.80 |
| एकूण** | 186.55 | 14,93,000 | 27,85,17,000 | 3,425.76 |
*"ऑफर केलेले शेअर्स" आणि "एकूण रक्कम" जारी किंमतीच्या श्रेणीच्या वरच्या मर्यादेचा वापर करून कॅल्क्युलेट केले जातात.
**अँकर इन्व्हेस्टरला (किंवा मार्केट मेकर्स) वाटप केलेले शेअर्स ऑफर केलेल्या एकूण शेअर्सच्या संख्येमधून वगळले जातात.
| तपशील (रु. कोटीमध्ये) | FY23 | FY24 | FY25 |
|---|---|---|---|
| महसूल | 7.19 | 15.84 | 25.61 |
| EBITDA | 1.52 | 2.55 | 6.16 |
| पॅट | 1.06 | 1.36 | 4.33 |
| तपशील (रु. कोटीमध्ये) | FY23 | FY24 | FY25 |
|---|---|---|---|
| एकूण मालमत्ता | 13.69 | 20.26 | 28.12 |
| शेअर कॅपिटल | 0.70 | 0.78 | 6.27 |
| एकूण कर्ज | 5.25 | 6.82 | 7.26 |
| तपशील (रु. कोटीमध्ये) | FY23 | FY24 | FY25 |
|---|---|---|---|
| ऑपरेटिंग उपक्रमांमधून/(वापरलेले) निव्वळ कॅश निर्माण | -0.32 | -3.80 | -0.16 |
| गुंतवणूक उपक्रमांमधून/(वापरलेले) निव्वळ कॅश निर्माण | -0.91 | -0.01 | 0.87 |
| फायनान्सिंग उपक्रमांमधून/(वापरलेले) निव्वळ कॅश निर्माण | 1.21 | 3.69 | 0.51 |
| कॅश आणि कॅश समतुल्यांमध्ये निव्वळ वाढ (कमी) | 0.01 | 0.12 | 0.19 |
सामर्थ्य
1. Experienced leadership and skilled workforce ensure consistent operations and strong strategic decision-making capabilities.
2. In-house quality assurance systems help maintain strict compliance and superior product quality standards.
3. Asset-light model reduces fixed costs through reliance on trusted contract manufacturers and distributors.
4. Strategic location near ports enables faster logistics, supporting efficient domestic and international operations.
कमकुवतता
1. Heavy dependence on third-party manufacturers limits control over production schedules and quality assurance.
2. Business relies mainly on export markets, exposing it to geopolitical and currency exchange risks.
3. Limited logistics partnerships may hamper flexibility in global supply chain and shipping operations.
4. Over-reliance on one freight forwarder poses risks to distribution continuity and timely deliveries.
संधी
1. Expand export of affordable generics to underserved markets with growing healthcare infrastructure needs.
2. Explore inorganic growth through acquisitions and strategic alliances in key global regions.
3. Leverage digital platforms and CRM tools to boost sales and customer engagement globally.
4. Increase contract manufacturer network to scale operations and diversify production capabilities efficiently.
धोके
1. Changing global regulations may increase compliance costs, impacting margins and operational flexibility.
2. Stiff competition in the generics segment can pressure pricing, market share, and profitability levels.
3. Quality control lapses could lead to product recalls, legal issues, and reputational damage.
4. Disruptions from pandemics or geopolitical events may severely affect export-driven revenue streams.
1. Asston’s revenue has grown from ₹7.19 crore to ₹25.61 crore in just two years.
2. FY25 margins are strong with EBITDA at 24.6% and PAT margin touching 17.3% levels.
3. Return ratios are impressive with RoE and RoCE both above 50%, showing efficient capital use.
4. Anchor investors subscribed ₹7.81 crore, adding credibility to this fairly valued SME IPO at ₹115–123.
1. Indian pharma exports reached $28.5 billion in first half 2025, growing ~13.4% year-over-year.
2. Domestic market projected to grow from ~$58 billion to $120–130 billion by 2030.
3. Indian CDMO market expanding at ~10.6% CAGR, from $8.1 billion in 2023 to ~$20 billion by 2032.
4. India holds 752 US FDA‑approved plants, strengthening global quality compliance and export capacity.
- कंपन्या
- प्रकार
- ओपनिंग तारीख
-
ॲडव्हिट ज्वेल्स
- मेनबोर्ड
- 23 जून
- प्री-बुक
-
वॉटरवेज लेजर टूरिजम
- मेनबोर्ड
- 23 जून
- प्री-बुक
एफएक्यू
Asston Pharmaceuticals IPO opens from July 9, 2025 to July 11, 2025.
The size of Asston Pharmaceuticals IPO is ₹27.56 कोटी.
The price band of Asston Pharmaceuticals IPO is fixed at ₹115 to ₹123 per share.
To apply for Asston Pharmaceuticals IPO, follow the steps given below:
● तुमच्या 5paisa अकाउंटमध्ये लॉग-इन करा आणि वर्तमान IPO सेक्शनमध्ये समस्या निवडा
● Enter the number of lots and the price at which you wish to apply for the Asston Pharmaceuticals IPO.
● तुमचा UPI ID प्रविष्ट करा आणि सबमिट करा वर क्लिक करा. यासह, तुमची बिड एक्सचेंजसह दिली जाईल.
तुम्हाला तुमच्या UPI ॲपमध्ये फंड ब्लॉक करण्यासाठी मँडेट नोटिफिकेशन प्राप्त होईल.
The minimum lot size of Asston Pharmaceuticals IPO is 2,000 shares and the investment required is ₹₹230,000.
The share allotment date of Asston Pharmaceuticals IPO is July 14, 2025
The Asston Pharmaceuticals IPO will likely be listed on July 16, 2025.
Sobhagya Capital Options Ltd. is the book running lead manager for Asston Pharmaceuticals IPO.
Asston Pharmaceuticals plans to utilise the raised capital from the IPO for:
- To fund machinery purchases for capital expenditure in the manufacturing unit.
- To meet the company's increased working capital requirements.
- To repay or prepay the company’s existing borrowings.
- सामान्य कॉर्पोरेट उद्देश.